ESRX is one that gets more attention from IBD than from me, but it did tage what looks like a breakout from a cup and handle pattern, but with a couple of key flaws: relatively low volume and a weak price relative line....(
read more)
Walgreen Company (NYSE:WAG) sales performance in August was, at best, weak, after the company posted a 4.5 percent sales decline to $5.85 billion from its $6.12 billion sales...(
read more)
Express Scripts Holding Company’s (ESRX) second-quarter 2012 adjusted earnings of 88 cents per share beat the Zacks Consensus Estimate of 82 cents and increased...(
read more)